These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1532265)

  • 1. The effects of OKT4A monoclonal antibody on cellular immunity of nonhuman primate renal allograft recipients.
    Wee SL; Stroka DM; Preffer FI; Jolliffe LK; Colvin RB; Cosimi AB
    Transplantation; 1992 Mar; 53(3):501-7. PubMed ID: 1532265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged survival of nonhuman primate renal allograft recipients treated only with anti-CD4 monoclonal antibody.
    Cosimi AB; Delmonico FL; Wright JK; Wee SL; Preffer FI; Jolliffe LK; Colvin RB
    Surgery; 1990 Aug; 108(2):406-13; discussion 413-4. PubMed ID: 2382234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humanized IgG1 and IgG4 anti-CD4 monoclonal antibodies: effects on lymphocytes in the blood, lymph nodes, and renal allografts in cynomolgus monkeys.
    Mourad GJ; Preffer FI; Wee SL; Powelson JA; Kawai T; Delmonico FL; Knowles RW; Cosimi AB; Colvin RB
    Transplantation; 1998 Mar; 65(5):632-41. PubMed ID: 9521196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Murine OKT4A immunosuppression in cadaver donor renal allograft recipients: a cooperative clinical trials in transplantation pilot study. Cooperative Clinical Trials in Transplantation Research Group.
    Transplantation; 1997 May; 63(9):1243-51. PubMed ID: 9158016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent CD8+ CTLs detected in anti-CD4 (OKT4A) MAb immunosuppressed cynomolgus recipients with prolonged allograft survival.
    Wee S; Kawai T; Knowles R; Colvin R; Cosimi AB
    Transplant Proc; 1993 Feb; 25(1 Pt 1):794-5. PubMed ID: 8438484
    [No Abstract]   [Full Text] [Related]  

  • 6. The development of a posttransplant TLI treatment strategy that promotes organ allograft acceptance without chronic immunosuppression.
    Thomas J; Alqaisi M; Cunningham P; Carver M; Rebellato L; Gross U; Patselas T; Araneda D; Thomas F
    Transplantation; 1992 Feb; 53(2):247-58. PubMed ID: 1531393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonhuman primate responses to murine and humanized OKT4A.
    Delmonico FL; Cosimi AB; Kawai T; Cavender D; Lee WH; Jolliffe LK; Knowles RW
    Transplantation; 1993 Apr; 55(4):722-8. PubMed ID: 8475542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppression of cynomolgus renal allograft recipients with humanized OKT4A monoclonal antibodies.
    Delmonico FL; Knowles RW; Colvin RB; Cavender DE; Kawai T; Bedle M; Stroka D; Preffer FI; Haug C; Cosimi AB
    Transplant Proc; 1993 Feb; 25(1 Pt 1):784-5. PubMed ID: 8438479
    [No Abstract]   [Full Text] [Related]  

  • 9. CDR-grafted OKT4A monoclonal antibody in cynomolgus renal allograft recipients.
    Powelson JA; Knowles RW; Delmonico FL; Kawai T; Mourad G; Preffer FK; Colvin RB; Cosimi AB
    Transplantation; 1994 Mar; 57(6):788-93. PubMed ID: 7908767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Murine OKT4A immunosuppression in cadaver donor renal allograft recipients: a Cooperative Clinical Trials in Transplantation pilot study.
    Transplantation; 1997 Apr; 63(8):1087-95. PubMed ID: 9133469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppression of canine renal allograft recipients by CD4 and CD8 monoclonal antibodies.
    Watson CJ; Cobbold SP; Davies HS; Rebello PR; Thiru S; McNair R; Rasmussen A; Waldmann H; Calne RY; Metcalfe SM
    Tissue Antigens; 1994 Mar; 43(3):155-62. PubMed ID: 7916496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OKT4A monoclonal antibody immunosuppression of cynomolgus renal allograft recipients.
    Cosimi AB; Delmonico FL; Wright JK; Wee SL; Preffer FI; Bedle M; Colvin RB
    Transplant Proc; 1991 Feb; 23(1 Pt 1):501-3. PubMed ID: 1990600
    [No Abstract]   [Full Text] [Related]  

  • 13. Function and surface phenotype of T lymphocytes infiltrating renal allografts in nonhuman primates treated with monoclonal antibodies.
    Nocera A; Cosimi AB; Colvin RB; Gesner ML; Fuller TC
    Transplantation; 1989 Nov; 48(5):732-41. PubMed ID: 2573179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-CD4 monoclonal antibody-induced allograft tolerance in rats despite persistence of donor-reactive T cells.
    Lehmann M; Graser E; Risch K; Hancock WW; Müller A; Kuttler B; Hahn HJ; Kupiec-Weglinski JW; Brock J; Volk HD
    Transplantation; 1997 Oct; 64(8):1181-7. PubMed ID: 9355837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The kinetics of tolerance induction by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) plus intravenous donor alloantigen administration.
    Motoyama K; Arima T; Yu S; Lehmann M; Flye MW
    Transplantation; 2000 Jan; 69(2):285-93. PubMed ID: 10670640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recipient memory-like lymphocytes remain unresponsive to graft antigens after CAMPATH-1H induction with reduced maintenance immunosuppression.
    Trzonkowski P; Zilvetti M; Friend P; Wood KJ
    Transplantation; 2006 Nov; 82(10):1342-51. PubMed ID: 17130784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal allograft-infiltrating lymphocytes. A prospective analysis of in vitro growth characteristics and clinical relevance.
    Kirk AD; Ibrahim MA; Bollinger RR; Dawson DV; Finn OJ
    Transplantation; 1992 Feb; 53(2):329-38. PubMed ID: 1371194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
    Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
    J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of donor specific transplantation tolerance to cardiac allografts following treatment with nondepleting (RIB 5/2) or depleting (OX-38) anti-CD4 mAb plus intrathymic or intravenous donor alloantigen.
    Arima T; Lehmann M; Flye MW
    Transplantation; 1997 Jan; 63(2):284-92. PubMed ID: 9020332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor-specific cellular immunity in rejecting and long-term-surviving class I-disparate rat renal allograft recipients.
    Ruiz P; Fuller J; Sanfilippo F
    Transplantation; 1990 Jan; 49(1):175-83. PubMed ID: 2301009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.